Molnupiravir Not To Be Included In Covid-19 Clinical Management Protocol

The ICMR’s National Task Force for COVID-19 has decided against including antiviral drug Molnupiravir in the Clinical Management Protocol for COVID-19 as of now, official sources said on Tuesday. The experts of the task force cited safety concerns and
http://dlvr.it/SGwHL0